Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000938206-25-000004
Filing Date
2025-02-14
Accepted
2025-02-14 07:48:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4711
  Complete submission text file 0000938206-25-000004.txt   6480
Mailing Address 25 EAST ERIE ST CHICAGO IL 60611
Business Address 25 EAST ERIE ST CHICAGO IL 60611 3125873800
DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000938206 (see all company filings)

EIN.: 203634295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Subject) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94678 | Film No.: 25623256
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)